Literature DB >> 7960770

[HIV-associated dermatoses and their prevalence in 456 HIV-infected patients. Relation to immune status and its importance as a diagnostic marker].

C Garbe1, R Husak, C E Orfanos.   

Abstract

Some 456 patients with HIV-associated skin disorders were documented in the HIV follow-up clinics at the Department of Dermatology, University Medical Center Steglitz, Berlin, during the years 1982-1992. Males comprised 91% of the patients. The most important risk groups for HIV infection were homosexual and bisexual men (77.9%) and individuals with intravenous drug abuse (12.7%). The most frequent dermatological diagnoses were oral candidosis (44.5%), seborrhoeic dermatitis (38.6%), folliculitis (32.9%) and Kaposi's sarcoma (23.5%). Altogether, 138 of the patients died during the time of observation. The most frequent cause of death was disseminated Kaposi's sarcoma (26.8%). A significant proportion of the patients developed skin diseases before significant reduction of the circulating CD4+ lymphocytes. In a still satisfactory immune situation, predominantly infections of the skin with dermatophytes (tinea), human papilloma viruses (warts) and bacteria (pyodermas) were observed. A considerable number of the HIV patients who developed zoster were also still in a favourable immune status; another 50% of these cases, however, developed the disease with reduced CD4+ lymphocyte count (< 300/microliters). Skin manifestations that tended to occur later in the course of HIV infection were oral candidosis, oral hairy leukoplakia, herpes genitoanalis, mollusca contagiosa and Kaposi's sarcoma, in spite of their early appearance in some cases. In the large majority of these patients the immunological parameters were already clearly reduced. Fungal, bacterial and viral infections of the skin, especially with extended skin involvement, may manifest themselves during the early phases of HIV infection. The number and severity of the skin manifestations increase with progressing immunosuppression, and treatment is often a difficult challenge for the dermatologist.

Entities:  

Mesh:

Year:  1994        PMID: 7960770     DOI: 10.1007/s001050050139

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  5 in total

1.  Orocutaneous Manifestations as Markers of Disease Progression in HIV Infection in Indian Setting.

Authors:  Y K Sharma; Mps Sawhney; D S Bhakuni; V Gera
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Hydroxyurea for the Treatment of Psoriasis including in HIV-infected Individuals: A Review.

Authors:  Eric S Lee; Misha M Heller; Faranak Kamangar; Kelly Park; Wilson Liao; John Koo
Journal:  Psoriasis Forum       Date:  2011

Review 3.  Update on imaging of non-infectious musculoskeletal complications of HIV infection.

Authors:  T C Booth; N C Chhaya; J R G Bell; B J Holloway
Journal:  Skeletal Radiol       Date:  2012-05-23       Impact factor: 2.199

4.  [Immunocytochemical venous blood studies in patients with manifest oral cavity carcinomas, oral precancerous conditions, benign tumors and in chronic alcoholic patients].

Authors:  R Dammer; E M Wurm; H Niederdellmann; H Fleischmann; R Knüchel
Journal:  Mund Kiefer Gesichtschir       Date:  1997-03

5.  Mucocutaneous Manifestations of HIV and the Correlation with WHO Clinical Staging in a Tertiary Hospital in Nigeria.

Authors:  Olumayowa Abimbola Oninla
Journal:  AIDS Res Treat       Date:  2014-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.